Galantamine.
Lowenthal
Mark N
MN
D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D017277:Drug Approval; D005702:Galantamine / Q000627:therapeutic use*; D006801:Humans; D007557:Israel
D002800:Cholinesterase Inhibitors; D005702:Galantamine